Cosentyx is a medication used to treat various inflammatory conditions such as psoriasis and psoriatic arthritis. It is a biologic drug that targets specific proteins in the immune system. According to the sources provided, there is limited information on the specific side effects of Cosentyx in pediatric patients.

The official website for Cosentyx states that it is approved for use in children aged 6 years and older with moderate to severe plaque psoriasis [2]. However, the website does not provide information on pediatric-specific side effects.

The drug patent watch website provides a list of potential side effects of Cosentyx, including upper respiratory infections, diarrhea, and headaches [1]. However, this information is not specific to pediatric patients.

The prescribing information for Cosentyx provided by Novartis, the manufacturer of the drug, does not provide any information on pediatric-specific side effects [3]. However, it does state that the safety and effectiveness of Cosentyx in pediatric patients have not been established for conditions other than moderate to severe plaque psoriasis.

In conclusion, while Cosentyx is approved for use in pediatric patients with moderate to severe plaque psoriasis, there is limited information on the specific side effects of the drug in this population. Patients and caregivers should discuss any potential risks and benefits of the medication with their healthcare provider.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/pediatric-psoriasis
[3] https://www.novartis.com/us-en/sites/novartis_us/files/cosentyx.pdf